Literature DB >> 16215814

Radiotherapy and chemotherapy of brain metastases.

R Soffietti1, A Costanza, E Laguzzi, M Nobile, R Rudà.   

Abstract

The authors have reviewed the results, the indications and the controversies regarding radiotherapy and chemotherapy of patients with newly diagnosed and recurrent brain metastases. Whole-brain radiotherapy, radiosurgery, hypofractionated stereotactic radiotherapy, brachytherapy and chemotherapy are the available options. New radiosensitizers and cytotoxic or cytostatic agents are being investigated. Adjuvant whole brain radiotherapy, either after surgery or radiosurgery, and prophylactic cranial irradiation in small-cell lung cancer are discussed, taking into account local control, survival, and risk of late neurotoxicity. Increasingly, the different treatments are tailored to the different prognostic subgroups, as defined by Radiation Therapy Oncology Group RPA Classes.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16215814     DOI: 10.1007/s11060-004-8096-3

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  134 in total

1.  Treatment of brain metastases of malignant melanoma with temozolomide.

Authors:  G Biasco; M A Pantaleo; S Casadei
Journal:  N Engl J Med       Date:  2001-08-23       Impact factor: 91.245

Review 2.  Radiotherapy for brain metastases.

Authors:  P J Hoskin; M Brada
Journal:  Clin Oncol (R Coll Radiol)       Date:  2001       Impact factor: 4.126

3.  Radiosurgery followed by planned observation in patients with one to three brain metastases.

Authors:  Johannes Lutterbach; Donatus Cyron; Karl Henne; Christoph B Ostertag
Journal:  Neurosurgery       Date:  2003-05       Impact factor: 4.654

4.  Factors affecting the risk of brain metastases after definitive chemoradiation for locally advanced non-small-cell lung carcinoma.

Authors:  T J Robnett; M Machtay; J P Stevenson; K M Algazy; S M Hahn
Journal:  J Clin Oncol       Date:  2001-03-01       Impact factor: 44.544

5.  The Case Against Prophylactic Cranial Irradiation in Limited Small Cell Lung Cancer.

Authors: 
Journal:  Semin Radiat Oncol       Date:  1995-01       Impact factor: 5.934

6.  A randomized phase III study of accelerated hyperfractionation versus standard in patients with unresected brain metastases: a report of the Radiation Therapy Oncology Group (RTOG) 9104.

Authors:  K J Murray; C Scott; H M Greenberg; B Emami; M Seider; N L Vora; C Olson; A Whitton; B Movsas; W Curran
Journal:  Int J Radiat Oncol Biol Phys       Date:  1997-10-01       Impact factor: 7.038

7.  Brain metastases as the only manifestation of an undetected primary tumor.

Authors:  L N Nguyen; M H Maor; M J Oswald
Journal:  Cancer       Date:  1998-11-15       Impact factor: 6.860

8.  Epidermal growth factor receptor targeted therapy by ZD 1839 (Iressa) in patients with brain metastases from non-small cell lung cancer (NSCLC).

Authors:  Federico Cappuzzo; Andrea Ardizzoni; Hector Soto-Parra; Cesare Gridelli; Paolo Maione; Marcello Tiseo; Cesare Calandri; Stefania Bartolini; Armando Santoro; Lucio Crinò
Journal:  Lung Cancer       Date:  2003-08       Impact factor: 5.705

9.  The cost effectiveness of stereotactic radiosurgery versus surgical resection in the treatment of solitary metastatic brain tumors.

Authors:  M J Rutigliano; L D Lunsford; D Kondziolka; M J Strauss; V Khanna; M Green
Journal:  Neurosurgery       Date:  1995-09       Impact factor: 4.654

10.  Central nervous system progression among patients with metastatic breast cancer responding to trastuzumab treatment.

Authors:  E Shmueli; N Wigler; M Inbar
Journal:  Eur J Cancer       Date:  2004-02       Impact factor: 9.162

View more
  12 in total

1.  Predicting compliance and survival in palliative whole-brain radiotherapy for brain metastases.

Authors:  Sebastià Sabater; Encarna Mur; Katrin Müller; Meritxell Arenas
Journal:  Clin Transl Oncol       Date:  2012-01       Impact factor: 3.405

2.  Consensus recommendations for a standardized brain tumor imaging protocol for clinical trials in brain metastases.

Authors:  Timothy J Kaufmann; Marion Smits; Jerrold Boxerman; Raymond Huang; Daniel P Barboriak; Michael Weller; Caroline Chung; Christina Tsien; Paul D Brown; Lalitha Shankar; Evanthia Galanis; Elizabeth Gerstner; Martin J van den Bent; Terry C Burns; Ian F Parney; Gavin Dunn; Priscilla K Brastianos; Nancy U Lin; Patrick Y Wen; Benjamin M Ellingson
Journal:  Neuro Oncol       Date:  2020-06-09       Impact factor: 12.300

3.  Increases in the number of brain metastases detected at frame-fixed, thin-slice MRI for gamma knife surgery planning.

Authors:  Aiko Nagai; Yuta Shibamoto; Yoshimasa Mori; Chisa Hashizume; Masahiro Hagiwara; Tatsuya Kobayashi
Journal:  Neuro Oncol       Date:  2010-09-23       Impact factor: 12.300

Review 4.  Lung cancer-associated brain metastasis: Molecular mechanisms and therapeutic options.

Authors:  Meysam Yousefi; Tayyeb Bahrami; Arash Salmaninejad; Rahim Nosrati; Parisa Ghaffari; Seyed H Ghaffari
Journal:  Cell Oncol (Dordr)       Date:  2017-09-18       Impact factor: 6.730

5.  Characteristics and prognosis of patients with colorectal cancer-associated brain metastases in the era of modern systemic chemotherapy.

Authors:  Ji Yeon Baek; Myoung Hee Kang; Yong Sang Hong; Tae Won Kim; Dae Yong Kim; Jae Hwan Oh; Seung Hoon Lee; Jin Hong Park; Jong Hoon Kim; Sun Young Kim
Journal:  J Neurooncol       Date:  2011-02-19       Impact factor: 4.130

6.  Brain metastases as the first symptom of lung cancer: a clinical study from an Asian medical center.

Authors:  Jia Jin; Xinli Zhou; Xiaohua Liang; Ruofan Huang; Zhaohui Chu; Jingwei Jiang; Qiong Zhan
Journal:  J Cancer Res Clin Oncol       Date:  2012-11-04       Impact factor: 4.553

7.  Surgical brain metastases: management and outcome related to prognostic indexes: a critical review of a ten-year series.

Authors:  Manuela Caroli; Andrea Di Cristofori; Francesca Lucarella; Fabio Angelo Raneri; Francesco Portaluri; Sergio Maria Gaini
Journal:  ISRN Surg       Date:  2011-09-20

8.  Treatment of single or multiple brain metastases by hypofractionated stereotactic radiotherapy using helical tomotherapy.

Authors:  Aiko Nagai; Yuta Shibamoto; Masanori Yoshida; Koichi Wakamatsu; Yuzo Kikuchi
Journal:  Int J Mol Sci       Date:  2014-04-22       Impact factor: 5.923

9.  Clinical analysis of patients who survived for less than 3 months after brain metastatectomy.

Authors:  Young Zoon Kim; Kyu Hong Kim; Joon Soo Kim; Yeong Jin Song; Ki Uk Kim; Hyung Dong Kim
Journal:  J Korean Med Sci       Date:  2009-07-29       Impact factor: 2.153

10.  Dexamethasone and supportive care with or without whole brain radiotherapy in treating patients with non-small cell lung cancer with brain metastases unsuitable for resection or stereotactic radiotherapy (QUARTZ): results from a phase 3, non-inferiority, randomised trial.

Authors:  Paula Mulvenna; Matthew Nankivell; Rachael Barton; Corinne Faivre-Finn; Paula Wilson; Elaine McColl; Barbara Moore; Iona Brisbane; David Ardron; Tanya Holt; Sally Morgan; Caroline Lee; Kathryn Waite; Neil Bayman; Cheryl Pugh; Benjamin Sydes; Richard Stephens; Mahesh K Parmar; Ruth E Langley
Journal:  Lancet       Date:  2016-09-04       Impact factor: 79.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.